Key result
Comorbidities are increasingly recognized as crucial components of the heart failure syndrome, especially in typical older patients who are often excluded from randomized controlled trials.
Why the study?
Comorbidities are increasingly recognized as crucial components of the heart failure syndrome, especially in typical older patients compared to highly selected trial participants.
Answers are grounded in this paper and cite their sources.
Highlights the increasing recognition of comorbidities as crucial components of the heart failure syndrome in typical older patients.
largest and most active committees of the Heart Failure Association (HFA) is the Committee on Comorbidities, which I have the honour to chair. It is in fact multiple committees, because its remit is so broad, covering study groups looking at Cardio-Oncology (Alex Lyon), Diabetes & Hypertension (Giuseppe Rosano), Cardiorenal Dysfunction (Wilfried Mullens), Heart & Brain (Andrew Coats), Cachexia, Sarcopenia and Frailty (Ewa Jankowska), and Lung Disease and Sleep Disorders (Mitja Lainscak). Co-morbidities are increasingly recognized as crucial components of the heart failure (HF) syndrome, especially in typical older patients (unlike the very highly selected patients who make in into randomized controlled trials). There has been much work published about these issues in the European Journal of Heart Failure recently. 1 -7
No takes yet. Share an insight, caveat, or question.
Andrew J.S. Coats (2019) studied Heart failure. Comorbidities are increasingly recognized as crucial components of the heart failure syndrome, especially in typical older patients who are often excluded from randomized controlled trials.
Synapse has enriched 10 related papers. Consider them for comparative context: